Antônio Sérgio Petrilli

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren et al. · The Lancet Oncology · 2019 · 324 citations

Interim Analysis, Lymphoid Neoplasia, Surgical Oncology +10

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 294 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Thrombosis +9

Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma

Bin Zhu, Roelof Koster, Eric Karlins et al. · JAMA Oncology · 2020 · 241 citations · Full text

Genome-wide association study identifies two susceptibility loci for osteosarcoma

Sharon A. Savage, Zhaoming Wang, Julie M. Gastier‐Foster et al. · Nature Genetics · 2013 · 202 citations · Full text

Genome-wide Association Study, Genetics, Genetic Epidemiology +4

Prognostic factors and outcomes for osteosarcoma: An international collaboration

Emilios E. Pakos, Andreas Nearchou, R. J. Grimer et al. · European Journal of Cancer · 2009 · 194 citations

International Collaboration, Medicine, Cancer Registration +4